Alsever's solution: Difference between revisions

Revision as of 16:28, 16 May 2014

Revision as of 07:46, 30 December 2014

Line 1:

'''Alsever's solution''' is a [[salinity|saline]] liquid used to prevent coagulation of human blood.<ref>Alsever, J. B., & Ainslie, R. B. (1941). A new method for the preparation of dilute blood plasma and the operation of a complete transfusion service. NY State J. Med, 41, 126-131.</ref><ref>{{cite book|last=Campbell|first=D. H.|title=Methods in Immunology. A Laboratory Text for Instruction and Research|date=1963|publisher=W. A. Benjamin, Inc.|___location=New York|page=244|coauthors=Garvey, J. S., Cremer, N. E. and Sussdorf, D. H.}}</ref> It is composed of an equal volume of 2.05% [[dextrose]], 0.8% [[sodium citrate]], 0.055% [[citric acid]], and 0.42% [[sodium chloride]]. This solution is used to study ''[[in vitro]]'' anti-inflammatory activity of crude drugs andby in[[HUMAN theRED HRBCBLOOD (humanCELL [[red blood cellSTABILIZATION]]) stabilization method.<ref>Gandhisan R, Thamaraichelvan A, Baburaj. Antiinflammatory action of Lannea coromandelica HRBC membrane stabilization. Fitotherapia 1991; 62: 82-83.</ref> It is also used to preserve blood cells from other sources.<ref>{{cite journal | doi = 10.1111/j.1699-0463.1953.tb00242.x| title = Experiments on the Stability of Sheep Erythrocytes Stored in Alsever's Solution| journal = Acta Pathologica Microbiologica Scandinavica| volume = 32| pages = 198| year = 2009| last1 = Schjerning-Thiesen| first1 = Knud}}</ref><ref>{{cite book| url= http://books.google.de/books?id=OLd91TkawxMC&pg=PA827 | page=827| title=L.S.A., List of C.F.R. Sections Affected| year=2003}}</ref>

==References==